<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04293523</url>
  </required_header>
  <id_info>
    <org_study_id>Sobi.Elocta-005</org_study_id>
    <nct_id>NCT04293523</nct_id>
  </id_info>
  <brief_title>A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health</brief_title>
  <acronym>A-MORE</acronym>
  <official_title>A 48-Month, Multi-Centre, Observational Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swedish Orphan Biovitrum</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Swedish Orphan Biovitrum</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 48-month observational, prospective, multicentre study. The overall aim of the
      study is to evaluate the long-term effectiveness of Elocta treatment on joint health in
      patients treated prophylactically with Elocta in a real-world setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Haemophilia A is a rare genetic disorder estimated to occur in one out of 10,000 live births,
      characterized by a deficiency in coagulation factor VIII causing impaired haemostasis and
      prolonged bleeding episodes. Moderate haemophilia, defined as &lt; 5%, and severe haemophilia,
      defined as &lt; 1% of normal factor VIII activity result in frequent and spontaneous bleeds into
      muscles and joints, commonly the elbows, knees, and ankles. Bleeding into joints can cause
      acute pain and swelling and can result in reduced joint range of motion, long-term cartilage
      damage and debilitating haemophilic arthropathy. Early use of prophylaxis with factor VIII
      replacement is recommended following diagnosis of haemophilia A to maintain joint health and
      prevent joint destruction. However, despite the use of prophylaxis many patients still
      experience joint bleeds which may lead to joint deterioration over time. The risk of joint
      bleeds increases with the amount of time spent below certain FVIII trough levels, e.g. 1, 3
      or 5 IU/dL. Thus, there is probably a relation between the intensity of the prophylactic
      treatment regimen and joint health. Elocta is an extended half-life rFVIII product (EHL
      rFVIII), with a slower clearance as compared to conventional FVIII products. Treatment with
      Elocta will therefore provide the treater with a greater flexibility for individualizing
      prophylaxis as compared to conventional FVIII. Higher trough levels can be reached with
      Elocta without increasing factor usage or injection frequency. The treater can instead choose
      to reduce the injection frequency or the factor consumption without lowering trough levels.

      The purpose of this study is to evaluate the effectiveness of Elocta on joint health over a
      long observation period (48 months). The study will explore the influence on long term joint
      health of different Elocta prophylaxis regimens leading to different trough levels.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 30, 2020</start_date>
  <completion_date type="Anticipated">September 2026</completion_date>
  <primary_completion_date type="Anticipated">September 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Joint health: Target joint development</measure>
    <time_frame>48 months</time_frame>
    <description>Number of target joints</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Joint health: Target joint resolution</measure>
    <time_frame>48 months</time_frame>
    <description>Number of resolved target joints</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Joint health: Target joint recurrence</measure>
    <time_frame>48 months</time_frame>
    <description>Number of recurring target joints</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Joint health: Annualised joint bleeding rate (AJBR) for treated bleeds</measure>
    <time_frame>48 months</time_frame>
    <description>Number of joint bleeding events per year, for treated bleeds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease Activity (hypertrophic synovium) and Disease Damage (Cartilage or Bone) scores for elbows, knees and ankles</measure>
    <time_frame>48 months</time_frame>
    <description>The Haemophilia Early Arthropathy Detection with UltraSound (HEAD-US) protocol will be used. The total score represents the sum of item scores for abnormalities detected. Its values range from 0 (minimum) to 8 (maximum). A higher score indicates a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Gait Score, and/or joint score items for elbows, knees and ankles.</measure>
    <time_frame>48 months</time_frame>
    <description>The Haemophilia Joint Health Score (HJHS) system will be used. Global Gait Score, and/or Joint score items (swelling, duration of swelling, muscle atrophy, axial alignment, crepitus on motion, flexion loss, instability, extension loss, joint pain, strength, gait) for elbows, knees and ankles.
The minimum score per joint is 0, the maximum score is 20. The overall total joint score (range 0-120) is the sum of the 6 six index joint (elbows, knees and ankles) scores. A higher score indicates a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint and physical evaluation for elbows, knees and ankles.</measure>
    <time_frame>48 months</time_frame>
    <description>The WFH Physical Examination Score (AKA Gilbert Score) will be used. Joint evaluation (pain, bleeding, physical examination and radiologic evaluation) and physical evaluation (swelling, muscle atrophy, axial deformity, crepitus on motion, range of motion, flexion contracture, and instability). A higher score indicates a worse outcome.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Annualised bleeding rate (ABR) for treated bleeds</measure>
    <time_frame>48 months</time_frame>
    <description>Number of bleeding events per year, for treated bleeds</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Annualised bleeding rate (ABR) for all bleeds</measure>
    <time_frame>48 months</time_frame>
    <description>Number of bleeding events per year, for all bleeds</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Proportion of patients with 0 joint bleeds</measure>
    <time_frame>48 months</time_frame>
    <description>Percentage (%) of study population with zero (0) joint bleeds</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Work productivity and impairment</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by WPAI-SHP questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Quality of Life</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by Haemo-QoL/Haem-A-QoL questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Physical activity level</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by the Saltin-Grimby scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Quality of Life</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by EQ-5D-5L/EQ-5D-Y questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Severity of joint health</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by Patient Global Impression of Severity of Joint Health questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: FVIII plasma levels</measure>
    <time_frame>48 months</time_frame>
    <description>Percentage (%) of FVIII plasma level</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Usage of pain and anti-inflammatory medication</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by medication dose</description>
  </other_outcome>
  <other_outcome>
    <measure>Effectiveness of Elocta: Usage of pain and anti-inflammatory medication</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by total number of exposure days per medication</description>
  </other_outcome>
  <other_outcome>
    <measure>Usage of Elocta: Annualised injection frequency per subject</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by prescription</description>
  </other_outcome>
  <other_outcome>
    <measure>Usage of Elocta: Annualised factor consumption per subject</measure>
    <time_frame>48 months</time_frame>
    <description>Assessed by prescription [IU/kg]</description>
  </other_outcome>
  <other_outcome>
    <measure>Usage of Elocta: Adherence</measure>
    <time_frame>48 months</time_frame>
    <description>Investigator assessed (Percentage (%))</description>
  </other_outcome>
  <other_outcome>
    <measure>Exploratory Objective</measure>
    <time_frame>48 months</time_frame>
    <description>Influence of different Elocta prophylaxis regimens on long term joint health</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Hemophilia A</condition>
  <arm_group>
    <arm_group_label>Hemophilia A patients</arm_group_label>
    <description>All patients diagnosed with haemophilia A regardless of severity, on factor treatment with Elocta according to usual clinical practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ELOCTA</intervention_name>
    <description>Extended half-life factor VIII product</description>
    <arm_group_label>Hemophilia A patients</arm_group_label>
    <other_name>ELOCTATE</other_name>
    <other_name>efmoroctocog alfa</other_name>
    <other_name>rFVIIIFc</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with haemophilia A regardless of severity, of any gender and age, on
        factor treatment with Elocta according to usual clinical practice.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provided signed and dated informed consent by the patient, or the patient's legally
             authorized representative(s) for patients under the legal age, before any
             study-related activities are undertaken. Assent should be obtained from paediatric
             patients according to local regulations

          -  Have a diagnosis of haemophilia A

          -  At enrolment on prophylactic treatment with Elocta, independent of participation in
             the study

        Exclusion Criteria:

          -  Enrolment in another concurrent clinical interventional study, or intake of an
             Investigational Medicinal Product (IMP), within three months prior to inclusion in
             this study

          -  Presence of factor VIII antibodies (inhibitors) (≥0.60 Bethesda Unit [BU]/mL) at the
             latest available inhibitor test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Lethagen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Swedish Orphan Biovitrum AB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sofia Bergenstråle</last_name>
    <phone>0046-8-697 27 47</phone>
    <email>sofia.bergenstrale@sobi.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Idah Larsson</last_name>
    <phone>0046-76-00 11 804</phone>
    <email>idah.larsson@sobi.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Antwerpen (UZA) Kinderhemato-oncologie</name>
      <address>
        <city>Edegem</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;National Specialized Hospital for Active Treatment of Haematologic Diseases Department of disorders of haemostasis and Department of thalassemias&quot;</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;University Hospital &quot;&quot;Queen Johanna-ISUL&quot;&quot; Pediatric Oncohematology Department&quot;</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital St Marina</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Centre Zagreb Pediatrics</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Centre Zagreb</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Brno</name>
      <address>
        <city>Brno</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Hradec Králové</name>
      <address>
        <city>Hradec Králové</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Plzeň Paediatric Clinic</name>
      <address>
        <city>Plzen</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Plzeň Zástupce vedoucího pro klinickou hematologii</name>
      <address>
        <city>Plzen</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dept. of Pediatric Haematology and Oncology, University Hospital Motol</name>
      <address>
        <city>Praha</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lastehaigla, Tallinn (Tallinn Children´s Hospital)</name>
      <address>
        <city>Tallinn</city>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The North Estonia Medical Centre Hematoloogiakeskus, Regionalhaigla</name>
      <address>
        <city>Tallinn</city>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital, New Children Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Turku University Central Hospital, Paediatric and adolescent haematology and oncology clinic</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charité-Universitätsmedizin Berlin Campus Virchow Klinikum</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kinder- und Jugendarzt-Praxis Blaubeuren</name>
      <address>
        <city>Blaubeuren</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn AöR, Institut für Experimentelle Hämatologie und Transfusionsmedizin</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gerinnungszentrum Rhein-Ruhr GZRR</name>
      <address>
        <city>Duisburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hämostaseologie/Hämophiliezentrum, Medizinische Klinik 2 Institut für Transfusionsmedizin, Universitätsklinikum</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt - Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hanover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Werlhof-Institut für Hämostaseologie GmbH</name>
      <address>
        <city>Hanover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SRH-Klinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>HZRM Hämöphilie Zentrum Rhein Main</name>
      <address>
        <city>Mörfelden-Walldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital am Universitätsklinikum München</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Laiko Hospital, Blood Transfusion Centre, National Reference Centre for Congenital Bleeding Disorders</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ippokrateio Hospital Thessaloniki (adult department)</name>
      <address>
        <city>Thessaloníki</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ippokrateio Hospital Thessaloniki (pediatric department)</name>
      <address>
        <city>Thessaloníki</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Haemophilia Centre and Haemostasis Department, Medical Centre of Hungarian Defence Forces</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Pécs</name>
      <address>
        <city>Pécs</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Policlinico Di Bari</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Bari Aldo Moro (Centro Emofilia Policlinico - Pediatria U.O.)</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Divisione Clinicizzata di Ematologia Policlinico Vittorio Emanuele</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AUSL Romagna Centro Emofilia U.O.C., Medicina Trasfusionale Dipartimento Patologia, Clinica Ospedale M. Bufalini</name>
      <address>
        <city>Cesena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Giannina Gaslini Institute</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hemophilia Center - University Hospital of Padua</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital of Parma, AOUP, Haemophilia Center</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Translational and Precision Medicine, Sapienza University Policlinic, &quot;Umberto 1&quot;</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Uo Malattie Emorragiche e Trombotiche Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universitá Catolica del Sacro Coure</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale Veris Delli Ponti</name>
      <address>
        <city>Scorrano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Città della Salute e della Scienza di Torino Regina Margherita</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale San Bortolo di Vicenza Haemophilia &amp; Thrombosis Center</name>
      <address>
        <city>Vicenza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mubarak Al-Kabeer Hospital</name>
      <address>
        <city>Kuwait City</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sabah Hospital</name>
      <address>
        <city>Kuwait City</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Farwaniya Hospital</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jahra Hospital</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Bank of Kuwait Specialized Hospital Sabah Central Region</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Luxembourg</name>
      <address>
        <city>Luxembourg</city>
        <country>Luxembourg</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen/UMCG</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Royal Hospital</name>
      <address>
        <city>Muscat</city>
        <country>Oman</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Servico Imuno-Hemoterapia Hospital de Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Universitaria de Porto</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hammad Hospital Qatar</name>
      <address>
        <city>Doha</city>
        <country>Qatar</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Prince Faisal Bin Bandar Cancer Centre</name>
      <address>
        <city>Gassim</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr Suliman Al Habib Hospital Riyadh</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>King Faisal Specialised Hospital, KFSH Riyadh, Children</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>King Faisal Specialist Hospital KFSH, Adults</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Riyadh Military Hospital (P.S.M.C)</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Ljubljana Division of Paediatrics</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sant Johan De Deu</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Cruces</name>
      <address>
        <city>Cruces</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Donostia</name>
      <address>
        <city>Donostia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Nieves</name>
      <address>
        <city>Granada</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Carlos Haya</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Navarro</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias (HUCA)</name>
      <address>
        <city>Oviedo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Son Espases</name>
      <address>
        <city>Palma De Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Alvaro Cunqueiro</name>
      <address>
        <city>Vigo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Univeristario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hematologimottagning Sahlgrenska</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital Malmö</name>
      <address>
        <city>Malmö</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor Inselspital</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHUV Unité d'Hémato-Oncologie Pédiatrique Consultation Thrombose et Hémostase Département femme-mère-enfant</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service et Laboratoire central d'hématologie, Adults</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zentrum für Labormedizin</name>
      <address>
        <city>Saint Gallen</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Zürich Klinik für Medizinische Onkologie und Hämatologie</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sheikh Khalifa Medical City Abu Dhabi</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tawam Hospital, Adults</name>
      <address>
        <city>Al ain</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tawam Hospital, Children</name>
      <address>
        <city>Al Ain</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>East Kent Hospitals University NHS Foundation Trust, Kent Haemophilia and Thrombosis Centre, Kent and Canterbury Hospital</name>
      <address>
        <city>Canterbury</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Leeds Teaching Hospitals NHS Trust, Saint James´s University Hospital</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Evelina London Children's Hospital, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Great Ormond Street Hospital, Royal London Hospital for Integrated Medicine</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Kuwait</country>
    <country>Luxembourg</country>
    <country>Netherlands</country>
    <country>Oman</country>
    <country>Portugal</country>
    <country>Qatar</country>
    <country>Saudi Arabia</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Arab Emirates</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2020</study_first_posted>
  <last_update_submitted>June 24, 2020</last_update_submitted>
  <last_update_submitted_qc>June 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Joint health</keyword>
  <keyword>HEAD-US</keyword>
  <keyword>HJHS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

